New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab

Overview of attention for article published in Lung Cancer: Targets and Therapy, July 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 101 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 36 publications that cite this research output.

36

The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.

In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody

Article in Scientific Reports (August 2023)

Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

Article in Journal for ImmunoTherapy of Cancer (February 2023)

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

Article in Cells (February 2023)